Two genes were identified as potential drivers of pulmonary arterial hypertension (PAH) in a bioinformatics study, offering opportunities to…
Articles by Margarida Maia, PhD
The first participant has entered ASCENT, a clinical study into the safety and tolerability of Liquidia’s Yutrepia, an inhaled…
While non-oral treatments for pulmonary arterial hypertension (PAH) can help ease symptoms, they can also make for poorer quality…
Delays beyond one year in the diagnosis of pulmonary arterial hypertension (PAH) lead to more hospitalizations, and this translates…
Babies with persistent pulmonary hypertension of the newborn (PPHN) started quickly on treatment with prostaglandin E1 (PGE1) — which…
People with pulmonary arterial hypertension (PAH) who have problems breathing while they’re sleeping — causing nocturnal hypoxemia, or oxygen…
The CorVista System, a point of care device that applies a machine learning algorithm to decode data, can predict the…
A heart transplant may resolve the pulmonary hypertension (PH) often found in children with heart failure — the organ’s…
Most adults with pulmonary arterial hypertension (PAH) experience no worsening and may even see a reduction in the severity…
The matrix around the heart’s cells does not shrink and may continue to undergo changes after pulmonary endarterectomy, or PEA,…
The gene coding for insulin-like growth factor 1 (IGF1) may be involved in both pulmonary hypertension (PH) and…
Engaging in inspiratory muscle training for eight weeks may help people with pulmonary hypertension (PH) strengthen their respiratory (breathing)…